Don S. Dizon

11.5k total citations · 3 hit papers
293 papers, 6.9k citations indexed

About

Don S. Dizon is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, Don S. Dizon has authored 293 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Oncology, 71 papers in Reproductive Medicine and 47 papers in Surgery. Recurrent topics in Don S. Dizon's work include Ovarian cancer diagnosis and treatment (68 papers), Cancer survivorship and care (49 papers) and Endometrial and Cervical Cancer Treatments (45 papers). Don S. Dizon is often cited by papers focused on Ovarian cancer diagnosis and treatment (68 papers), Cancer survivorship and care (49 papers) and Endometrial and Cervical Cancer Treatments (45 papers). Don S. Dizon collaborates with scholars based in United States, Netherlands and Switzerland. Don S. Dizon's co-authors include Carol Aghajanian, Paul Sabbatini, David R. Spriggs, C.O. Granai, Martee L. Hensley, Mary C. Politi, Richard T. Penson, Michael A. Thompson, Kathleen N. Moore and Neel Shah and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Don S. Dizon

267 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

2016 295 citations Alexi A. Wright, Kari Bohlke et al. Journal of Clinical Oncology profile →
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

2016 274 citations Alexi A. Wright, Kari Bohlke et al. profile →
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update

2023 105 citations Barbara L. Andersen, Christina Lacchetti et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Don S. Dizon United States	49	2.8k	1.8k	1.5k	1.1k	1.0k	293	6.9k
Noriyuki Katsumata Japan	38	2.8k 1.0×	1.3k 0.7×	776 0.5×	990 0.9×	1.2k 1.2×	183	5.7k
Usha Menon United Kingdom	53	3.2k 1.1×	3.0k 1.6×	2.6k 1.7×	1.2k 1.1×	910 0.9×	305	10.6k
Susana Banerjee United Kingdom	43	3.6k 1.3×	2.4k 1.3×	2.1k 1.4×	870 0.8×	609 0.6×	307	7.0k
Paul Sabbatini United States	45	4.0k 1.4×	2.5k 1.4×	1.8k 1.2×	1.2k 1.1×	1.5k 1.4×	182	8.8k
James Paul United Kingdom	43	2.5k 0.9×	1.3k 0.7×	1.4k 0.9×	458 0.4×	1.2k 1.2×	181	5.9k
Richard T. Penson United States	48	5.2k 1.8×	3.3k 1.8×	3.3k 2.2×	1.4k 1.3×	1.2k 1.2×	241	10.6k
Lari Wenzel United States	36	2.5k 0.9×	2.3k 1.2×	483 0.3×	1.1k 1.0×	1.6k 1.6×	144	6.3k
Edward E. Partridge United States	49	2.8k 1.0×	3.8k 2.1×	1.4k 0.9×	2.6k 2.4×	2.4k 2.3×	195	9.9k
Lois M. Ramondetta United States	36	1.8k 0.6×	1.7k 0.9×	1.1k 0.7×	2.9k 2.7×	1.1k 1.1×	215	6.1k
Rosemary D. Cress United States	38	3.9k 1.4×	935 0.5×	812 0.5×	550 0.5×	941 0.9×	128	6.9k

Countries citing papers authored by Don S. Dizon

Since Specialization

Citations

This map shows the geographic impact of Don S. Dizon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don S. Dizon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don S. Dizon more than expected).

Fields of papers citing papers by Don S. Dizon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don S. Dizon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don S. Dizon. The network helps show where Don S. Dizon may publish in the future.

Co-authorship network of co-authors of Don S. Dizon

This figure shows the co-authorship network connecting the top 25 collaborators of Don S. Dizon. A scholar is included among the top collaborators of Don S. Dizon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don S. Dizon. Don S. Dizon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Groisberg, Roman, Andrew Elliott, Don S. Dizon, et al.. (2025). Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma. Clinical Cancer Research. 31(11). 2210–2221.

El‐Jawahri, Areej, Jennifer Barsky Reese, Lara Traeger, et al.. (2024). Randomized Trial of a Multimodal Intervention to Enhance Sexual Function and Quality of Life (QOL) in Hematopoietic Stem Cell Transplant (HSCT) Survivors. Transplantation and Cellular Therapy. 30(2). S342–S342.

Cathcart-Rake, Elizabeth, et al.. (2024). Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer. CA A Cancer Journal for Clinicians. 75(1). 68–81. 4 indexed citations

Newcomb, Richard, Lara Traeger, Jennifer Barsky Reese, et al.. (2024). Design and Development of a Multimodal Digital Intervention (SHIFT App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant (HSCT) Survivors. Transplantation and Cellular Therapy. 30(11). 1106.e1–1106.e13. 2 indexed citations

Enzinger, Andrea C., Hajime Uno, Christine Cronin, et al.. (2024). Effects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial. JNCI Journal of the National Cancer Institute. 116(7). 1137–1144. 3 indexed citations

Hassett, Michael J., Christine Cronin, Deborah Schrag, et al.. (2024). Strategies for implementing an electronic patient-reported outcomes-based symptom management program across six cancer centers. BMC Health Services Research. 24(1). 1386–1386. 3 indexed citations

Ghosh, Deepraj, et al.. (2023). Spatial Heterogeneity in Cytoskeletal Mechanics Response to TGF-β1 and Hypoxia Mediates Partial Epithelial-to-Mesenchymal Transition in Epithelial Ovarian Cancer Cells. Cancers. 15(12). 3186–3186. 5 indexed citations

Andersen, Barbara L., Christina Lacchetti, Kimlin Ashing, et al.. (2023). Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 41(18). 3426–3453. 105 indexed citations breakdown →

Florez, Narjust, et al.. (2022). Social Media and the Quest for Equity and Diversity in Oncology: On Safe Spaces and the Concept of the Public Physician. JCO Oncology Practice. 18(8). 572–577.

10.

Alpert, Ash B., Jamie R. Brewer, John R. Blosnich, et al.. (2022). Addressing Barriers to Clinical Trial Participation for Transgender People With Cancer to Improve Access and Generate Data. Journal of Clinical Oncology. 41(10). 1825–1829. 12 indexed citations

11.

Graff, Stephanie L., Tanya M. Wildes, Narjust Duma, et al.. (2022). Understanding Modern Medical Centers: Beyond Simone—Intersectional Maxims for a New Era. Journal of Clinical Oncology. 41(7). 1350–1358. 1 indexed citations

12.

Yang, Andrew, et al.. (2022). Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient Setting. JCO Oncology Practice. 18(10). e1641–e1647. 3 indexed citations

13.

Goldberg, Elizabeth M., Rochelle K. Rosen, Don S. Dizon, et al.. (2022). Using Social Media for Clinical Research: Recommendations and Examples From the Brown-Lifespan Center for Digital Health. Journal of Medical Internet Research. 24(6). e35804–e35804. 4 indexed citations

14.

Hlubocky, Fay J., Banu Symington, Daniel C. McFarland, et al.. (2021). Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization’s Response for Readiness, Mitigation, and Resilience. JCO Oncology Practice. 17(7). 365–374. 51 indexed citations

15.

Alpert, Ash B., George A. Komatsoulis, Stephen C. Meersman, et al.. (2021). Identification of Transgender People With Cancer in Electronic Health Records: Recommendations Based on CancerLinQ Observations. JCO Oncology Practice. 17(3). e336–e342. 10 indexed citations

16.

Freire, Andrea P. Espejo, Andrew Elliott, Andrew E. Rosenberg, et al.. (2021). Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis. Cancers. 13(19). 4816–4816. 44 indexed citations

17.

Marron, Jonathan M., Don S. Dizon, Banu Symington, Michael A. Thompson, & Abby R. Rosenberg. (2020). Waging War on War Metaphors in Cancer and COVID-19. JCO Oncology Practice. 16(10). 624–627. 23 indexed citations

18.

Wright, Alexi A., Kari Bohlke, Deborah K. Armstrong, et al.. (2016). Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Obstetrical & Gynecological Survey. 71(12). 717–718. 19 indexed citations

19.

Lum, Lawrence G., Archana Thakur, Zaid Al‐Kadhimi, et al.. (2015). Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial. Clinical Cancer Research. 21(10). 2305–2314. 87 indexed citations

20.

Carmen, Marcela G. del, et al.. (2014). CA 125 and Epithelial Ovarian Cancer: Role in Screening, Diagnosis, and Surveillance. 10(6). 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact